AbbVie Inc. News Headlines

Get ABBV Alerts
*Delayed - data as of Nov. 20, 2014  -  Find a broker to begin trading ABBV now
Exchange: NYSE
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By
Achillion Pharmaceuticals: Still Bullish, But Taking Profits
11/12/2014 5:06:00 PM - Seeking Alpha

Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog
11/12/2014 5:00:00 PM -

Gilead Sciences Gets Ambushed By The Patent Troll, AbbVie
11/12/2014 3:25:00 PM - Seeking Alpha

Regeneron/Sanofi Announce Positive Dupilumab Study Data - Analyst Blog
11/12/2014 11:00:00 AM -

Earnings Triple Plays
11/12/2014 2:54:00 AM - Seeking Alpha

SUPN Revises Revenue Outlook Upward, EVDY Fit And Fine, NASDAQ Warning For ACST
11/11/2014 10:40:00 PM - RTT News

SUPN Revises Revenue Outlook Upward, EVDY Fit And Fine, NASDAQ Warning For ACST
11/11/2014 10:40:00 PM - RTT News

Bristol-Myers Gives Updates on HCV Candidate Daclatasvir - Analyst Blog
11/11/2014 6:41:00 PM -

Galapagos - AbbVie's Best Bet For Staying Market Leader In Rheumatoid Arthritis Post Humira?
11/11/2014 3:45:00 PM - Seeking Alpha

Re-Examining My Bullish Thesis On Walgreen
11/11/2014 2:04:00 PM - Seeking Alpha

Why Is Gilead Always Holding The Ace? A Prediction Of The Future HCV Market And What Analysts Aren't Talking About
11/11/2014 11:13:00 AM - Seeking Alpha

Gilead presents Harvoni data
11/11/2014 11:03:00 AM - Seeking Alpha

Are Expensive Biotech Drugs Bad For Business?
11/11/2014 10:45:00 AM - Seeking Alpha

Stock Market News for November 11, 2014 - Market News
11/11/2014 10:10:00 AM -

AbbVie Reports Results From Studies In Hepatitis C Patients - Quick Facts
11/11/2014 9:28:00 AM - RTT News

Gilead presents data from three HCV drug combo studies
11/11/2014 9:05:00 AM - Seeking Alpha

Repros Soars on Positive FDA Meeting Regarding Androxa - Analyst Blog
11/10/2014 5:20:00 PM -

Merck Reports Interim Data on Hepatitis C Virus Drug - Analyst Blog
11/10/2014 4:45:00 PM -

Closing Update: Stocks Eke Out Gains as Transports Fuel Another Higher Close
11/10/2014 4:20:15 PM - MT Newswires

Emergent BioSolutions Beats on Q3 Earnings, Guidance Up - Analyst Blog
11/10/2014 12:30:00 PM -

Merck's Shortened Hep C Regimens Fall Short of Cure-Rate Goal
11/9/2014 6:23:00 PM - TheStreet

Google's "Cancer Pill": Revolutionary or Ridiculous?
11/9/2014 2:24:02 PM - Motley Fool

3 Biotech Stocks to Watch in November
11/8/2014 11:03:17 AM - Motley Fool

Gilead (GILD) Submits HIV Combination Drug for FDA Review - Analyst Blog
11/7/2014 6:50:00 PM -

Novartis' (NVS) LBH589 Gets Unfavorable FDA Panel Opinion - Analyst Blog
11/7/2014 5:20:00 PM -